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Abstract 
Background: Differences in cortisol secretion may differentiate individuals at high compared to low genetic risk 
for bipolar disorder (BD) and predict the onset or recurrence of mood episodes. The objectives of this study were to 
determine if salivary cortisol measures are: (1) different in high‑risk offspring of parents with BD (HR) compared to 
control offspring of unaffected parents (C), (2) stable over time, (3) associated with the development of mood episode 
onset/recurrence, and (4) influenced by comorbid complications.
Methods: Fifty‑three HR and 22 C completed salivary cortisol sampling annually for up to 4 years in conjunction with 
semi‑structured clinical interviews. The cortisol awakening response (CAR), daytime cortisol [area under the curve 
(AUC)], and evening cortisol (8:00 p.m.) were calculated.
Results: There were no differences in baseline CAR, AUC and evening cortisol between HR and C (p = 0.38, p = 0.30 
and p = 0.84), respectively. CAR, AUC and evening cortisol were stable over yearly assessments in HR, while in Cs, 
evening cortisol increased over time (p = 0.008), and CAR and AUC remained stable. In HR, AUC and evening corti‑
sol increased the hazard of a new onset mood disorder/recurrence by 2.7 times (p = 0.01), and 3.5 times (p = 0.01), 
respectively, but this was no longer significant after accounting for multiple comparisons.
Conclusions: Salivary cortisol is stable over time within HR offspring. However, between individuals, basal salivary 
cortisol is highly variable. More research is needed, with larger samples of prospectively studied HR youth using a 
more reliable method of cortisol measurement, to determine the potential role of cortisol in the development of 
mood disorders.
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Background
Bipolar disorder (BD) is a complex psychiatric disorder 
that runs in families and is associated with high indi-
vidual and societal burden (Judd et al. 2005; Kozloff et al. 
2010). Afflicted individuals often endure years of impair-
ing illness before receiving the appropriate diagnosis 
(Hirschfeld et al. 2003) and among individuals at genetic 
risk, non-specific manifestations develop early in adoles-
cence (Duffy et  al. 2014; Keown-Stoneman et  al. 2015). 
Delayed diagnosis, and sub-optimal treatment contrib-
ute to the substantial burden of illness and poor quality 
of remission (Hirschfeld et al. 2003; Schaffer et al. 2006). 
The high heritability of BD is well established; however, 
identified susceptibility genes have so far explained only 
a small proportion of the risk (McGuffin et  al. 2003; 
Farmer et al. 2007; Gottesman et al. 2010). The identifi-
cation of reliable risk indicators and neurobiological tar-
gets for intervention in BD is a priority with widespread 
implications for improving earlier accurate detection and 
developing specific preventive measures.
Hypothalamic–pituitary–adrenal (HPA) axis dys-
regulation is the most consistent biological predictor of 
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mood episode recurrence in both BD and melancholic 
depressed patients (Carroll et al. 1981; Duffy et al. 2012), 
while non-suppression to dexamethasone challenge has 
been used as a barometer for illness activity (Deshauer 
et al. 1999; Stetler and Miller 2011). The HPA axis is cen-
tral in controlling reactions to stress and regulating emo-
tional processes and there is an established association 
between mood symptoms and hypercortisolaemic states 
providing strong evidence of the biological plausibility of 
this association (Duffy et al. 2012).
The magnitude of association between basal cortisol 
and mood episodes is small to moderate, reflecting het-
erogeneity of clinical subtypes, medication, age, time of 
day, and endocrine methods, making studies difficult 
to compare and interpret. A meta-analysis of studies 
examining basal and post-challenge HPA axis measures 
suggests that major depression is associated with only a 
small to moderate increase in basal cortisol and adren-
ocorticotropic hormone (ACTH), and a decrease in 
corticotrophin-releasing hormone (CRH) levels among 
studies taking into account medication use, diagnostic 
heterogeneity, and age; while studies not taking these fac-
tors into account reported stronger associations between 
HPA axis function and depression (Stetler and Miller 
2011).
There are few published longitudinal studies examin-
ing whether elevated cortisol is associated with the sub-
sequent onset of mood disorders in offspring at high-risk 
for BD. The majority of research has been completed in 
older patients with established illness, and as such is lim-
ited by burden of illness confounds. As individuals age, 
the cumulative effect of acute psychiatric episodes, resid-
ual symptoms, and treatment effects over the life span 
makes the association between cortisol and subsequent 
mood episodes difficult to disentangle.
A small number of studies have reported elevated 
morning salivary cortisol (Goodyer et  al. 2000; Halligan 
et  al. 2004, 2007; Mannie et  al. 2007) and evening uri-
nary cortisol (Rao et al. 2009) in unaffected and remitted 
offspring of depressed parents compared to offspring of 
well parents and a longitudinal association with subse-
quent depressive symptoms; however, other studies have 
not replicated this finding including a large prospective 
cohort study taking into account a number of important 
confounding factors (Carnegie et al. 2014). Of note, some 
of these studies did not report a significant difference in 
evening salivary cortisol between offspring at high risk 
for unipolar depression compared to control offspring of 
unaffected parents (Halligan et al. 2004; Rao et al. 2009). 
Ellenbogen et  al. published a number of studies dem-
onstrating evidence of higher mean cortisol awakening 
response (CAR) and daily cortisol secretion as measured 
by area under the curve (AUC) among the adolescent 
offspring of parents with BD compared to well parents 
(Ellenbogen et  al. 2004; Ellenbogen et  al. 2006). How-
ever, this finding was not replicated in the same sample at 
an older age, although high-risk offspring still exhibited 
higher afternoon salivary cortisol over a two-week period 
compared to controls (Ellenbogen et al. 2010) and there 
was evidence that morning cortisol predicted the devel-
opment of major mood episodes (Ellenbogen et al. 2011). 
In a small pilot study using the Flourish Canadian high-
risk cohort, there was evidence of an elevated cortisol 
awakening response in remitted BD patients and in the 
first 30  min after awakening in their high-risk offspring 
(Deshauer et  al. 2003, 2006). There is also preliminary 
evidence of differences in neurotrophic and immunologi-
cal markers between high-risk offspring of a bipolar par-
ent and control offspring of well parents and in the early 
compared to later stages of illness development in high-
risk offspring (Duffy et  al. 2014). Differences in basal 
cortisol among high-risk offspring compared to controls 
and the association with major mood episodes in high-
risk offspring suggest that differences in HPA axis indi-
ces may reflect a genetic vulnerability associated with BD. 
However, the findings to date are mixed, and further rep-
lication in high-risk samples is necessary to confirm this 
theory.
The objectives of this paper are to: (1) determine if there 
are differences in salivary cortisol in offspring of parents 
with BD compared to offspring of unaffected parents, (2) 
describe the stability of salivary cortisol measures within 
high-risk  and control offspring over several years, (3) 
determine the longitudinal association between salivary 
cortisol and risk of mood episodes in high-risk offspring 
and (4) explore the influence of frequent complications of 
BD, including psychotic symptoms and substance use dis-
orders (SUD), on the association between cortisol and risk 
of mood disorder in high-risk offspring. We hypothesized 
that indices of daytime cortisol secretion (AUC), morning 
awakening response (CAR) and evening salivary cortisol, 
would be elevated and less stable in high-risk compared to 
control offspring, and that psychotic symptoms and SUD 
would be an effect modifier.
Methods
Participants
Participants were a subset of high-risk and control off-
spring from the Flourish Canadian Offspring Cohort 
Study, which is an ongoing, dynamic, prospective cohort 
study based in Ontario that began in 1996. Descriptions of 
this study cohort are given in detail elsewhere (Duffy et al. 
2009, 2010, 2014). Briefly, offspring were considered eli-
gible for recruitment into the study if they were between 
the ages of five and 25 years. High-risk offspring had one 
parent with confirmed BD I or II at baseline and no other 
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major psychiatric comorbidity. Their other biological par-
ent was also confirmed to have no major psychiatric dis-
order at baseline. Control offspring were eligible if both of 
their parents were confirmed to have no major psychiat-
ric disorder (psychosis, SUD or major mood disorder) at 
baseline. Offspring were excluded if they were unable to 
comprehend or comply with the study protocol. All diag-
noses in the parents were made by expert psychiatrists 
in accordance with DSM-IV-TR criteria following sched-
ule for affective disorders: present and lifetime (SADS-
PL) (Endicott and Spitzer 1978) interviews and were 
confirmed through a consensus review with at least two 
additional research psychiatrists blind to family affilia-
tion. For this sub-study, we included consenting/assenting 
high-risk and control offspring over the age of seven years 
from the larger cohort. At the time of sampling, all off-
spring were either unaffected for lifetime mood disorder 
or in clinical remission based on semi-structured clini-
cal research interview and established cutoff scores on 
the Beck Depression Inventory (BDI) (Beck and Beames-
derfer 1974) and hypomania checklist revised (Young 
et al. 1978). All offspring/parents completed an informed 
consent/assent form. This research was approved by the 
local research ethics boards (Ottawa Institutional Review 
Board and the IWK Research Ethics Board in Halifax).
Procedure
High-risk and control offspring completed annual clini-
cal assessments with expert psychiatrists following Kid-
die SADS-PL (Axelson et  al. 2003)/SADS-PL (Endicott 
and Spitzer 1978) interviews and completed a self-report 
measure of life stress (Goodyer et  al. 1990, 1997) dur-
ing each annual visit. Socio-economic status (SES) was 
measured in the parents using the Hollingshead SES 
scale; a composite measure of both working spouses’ 
education and occupation (Hollingshead 1970). During 
the annual research visit, consenting offspring and their 
parents were given oral and written detailed instruc-
tions on the salivary cortisol collection protocol. Saliva 
was collected using five-ml free drool Sarstedt plastic 
cryovials. On three consecutive routine weekdays, off-
spring provided salivary samples four times a day, upon 
awakening (T0), 30 min later (T1), 60 min later (T2) and 
at 8:00 p.m. (T3). Offspring were instructed to not brush 
their teeth, smoke, eat or drink anything with the excep-
tion of water before their T0, T1 and T2 samples, and 1 h 
before their T3 sample. Offspring were also instructed 
not to perform any vigorous exercise one hour prior 
to their salivary samples and not drink alcohol during 
their three sampling days. Offspring recorded their date 
and time of sampling for every sample, their sleep qual-
ity and ease of waking quality on each consecutive sam-
pling day, and their mood symptoms (Kent et al. 1997) on 
one of the three consecutive sampling days. Consenting 
offspring repeated the 3-day cortisol assessment after 
their subsequent annual clinical interviews. The range of 
repeated assessments after yearly clinical interviews was 
2.0–3.5  years in high-risk and 0.9–3.0  years in control 
offspring. Samples were kept frozen in the subjects’ own 
freezers and transported on ice to the laboratory. Salivary 
cortisol levels were measured in batches (by year) using 
an enzyme immunoassay kit according to the kit instruc-
tions (Salimetrics, State College, PA, USA). The intra-
assay coefficient of variation was 2.1  %. Four batches 
were analyzed and the inter-assay coefficient of variation 
(using different reference sample concentrations) was 1.9, 
0.0, 3.9 and 3.0  %. The minimum detectable concentra-
tion of cortisol for all batches was 0.33 nmol/L.
Measures
Salivary cortisol levels were averaged over the three con-
secutive sampling days at each time point for each sam-
pling year to account for day to day variation. To replicate 
findings from other studies, we were interested in meas-
uring the rise in cortisol upon awakening, an integrated 
index of daytime secretion of cortisol, and evening corti-
sol. To measure these indices of HPA axis activity, we cal-
culated the mean CAR (T1 minus T0), mean area under 
the curve ground (AUC) (T0, T1 and T3), and mean T3 
(8:00 p.m.) cortisol, respectively. Owing to considerable 
missing data at 60  min (T2), CAR was calculated using 
only the second morning sample (T1: 30 min post-awak-
ening). We were confident that we were able to capture 
the awakening response using 30  min post-awakening, 
and there is evidence of similar cortisol concentrations 
at 30 and 60 min post-awakening in patients with major 
depression (McAllister-Williams et  al. 2015). Daytime 
secretion was measured by AUC ground (Pruessner et al. 
2003), comprising the total area under the absolute cor-
tisol measurements at T0, T1 and T3. Evening cortisol 
was measured by the mean of the three evening cortisol 
samples at 8:00 p.m. (T3). Life stress was measured using 
the recent life events and difficulties questionnaire (LEQ) 
(Goodyer et al. 1990, 1997) during annual clinical inter-
views and mood symptoms were measured during one of 
the three consecutive sampling days of the salivary cor-
tisol collection using the Mood and Feelings Question-
naire (MFQ) (Kent et al. 1997). The LEQ and MFQ both 
have established reliability and validity in this population 
(Goodyer et  al. 1990; Daviss et  al. 2006). Sleep quality 
and ease of waking during the sampling collection were 
captured using the subjective sleep rating scale (Bertocci 
et al. 2005); a seven-item self-report shortened measure 
of the Pittsburgh sleep index (Buysse et al. 1989). For the 
sleep items, participants rated their response on a 100-
point scale ranging from 0 (very bad, very difficult) to 100 
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(very good, very easy). The sleep ratings were averaged 
over the three day sampling period. Pubertal status was 
collected at the time of sample collection using the Peter-
son Pubertal Development Scale (PPDS) (Petersen et al. 
1988). The PPDS has demonstrated good reliability and 
validity (Petersen et al. 1988).
Lifetime psychotic symptoms and/or SUD were cap-
tured during the annual KSADS-PL/SADSL-PL clinical 
interviews. Lifetime psychotic symptoms included symp-
toms that occurred either inside or outside (psychosis 
not otherwise specified) of mood episodes. We intended 
on including lifetime hospitalizations; however, only one 
participant from this analysis was hospitalized. The off-
spring in this analysis were still in the early stages of ill-
ness development, and therefore had minimal history of 
pharmacological treatment (Duffy et al. 2014).
Data analysis
Cox proportional hazard models, with sandwich estima-
tors to account for sibling correlation (clustering within 
families) and time-varying covariates to account for sam-
pling year, were estimated to determine the association 
between the pattern of cortisol values over time and the 
development of a new onset mood disorder and major 
mood episode recurrences (hypomania, mania, major 
depression) over follow-up from date of birth. All sur-
vival models were checked for proportionality. Date of 
birth was used rather than date of baseline interview as 
this study uses an open, dynamic cohort design where 
subjects enter the study at different ages and dates. Date 
of last interview was used as a censoring variable. Mixed 
models with random intercepts to account for sibling cor-
relation were used to test for differences in baseline cor-
tisol measures between high-risk and control offspring. 
Mixed models were also used to determine the stability 
of cortisol measurements over repeated sampling years 
using an autoregressive correlation structure, accounting 
for correlation among measurements taken on the same 
individual over multiple years. Independent interaction 
terms were included in the mixed model to determine 
if complications (i.e., psychotic symptoms  ×  sampling 
year and SUD × sampling year) influenced the stability of 
cortisol over time. Cortisol levels pertaining to AUC and 
evening cortisol (T3) were log transformed using the nat-
ural logarithm to accommodate the normality assump-
tion of all mixed models. Normality of the outcome is 
not a required assumption for Cox proportional hazard 
models, and therefore cortisol levels pertaining to these 
models were untransformed.
All models were adjusted for age of offspring at baseline 
cortisol sample, and sibling correlation. Models pertain-
ing to high-risk offspring only were additionally adjusted 
for sex. Multiple comparisons were accounted for using 
the Šidák correction for multiple comparisons.
To minimize the impact of missing data, each subject’s 
cortisol measurements at T0, T1, T2 and T3 were aver-
aged over the three collection days within each year for 
the four separate years per subject. This yielded an aver-
age T0, T1, T2 and T3 cortisol value for each repeated 
annual assessment. For example, if a subject had missing 
data for one day, the average was calculated using the two 
other available days. Any subjects that were missing cor-




Fifty-three high-risk and 22 control offspring completed 
the baseline (year 1) cortisol sampling study. High-risk 
and control offspring did not differ significantly on base-
line characteristics except for body mass index (BMI), 
where BMI was higher in controls (p =  0.01) (Table  1). 
Sixty-eight percent of high-risk offspring and 55  % of 
controls were female (p  =  0.27). All control offspring 
and 77 % of HR offspring had completed puberty at base-
line or were in Tanner pubertal stage IV. The mean age 
at cortisol sampling in year 1 was 20.0  years (standard 
deviation (SD)  =  7.2, range  =  11.3–33.1) in high-risk 
and 20.8 years (SD = 2.8) in control offspring. Seventeen 
(32 %) high-risk offspring had a lithium-responsive par-
ent while 36 (68 %) had a lithium non-responsive parent. 
The median and range of sample times across repeated 
sampling years can be found in Additional file 1: Table S1.
Follow‑up
Thirty-two high-risk offspring completed a second repeat 
cortisol measurement after their subsequent annual 
research visit, 21 completed a third repeat cortisol meas-
urement and six a fourth repeat cortisol measurement. 
In the controls, eight completed a second repeat cortisol 
measurement, and two completed a third repeat meas-
urement. No controls completed a fourth repeat meas-
urement. In total, 60  % (32/53) of high-risk offspring 
did not complete up to three repeated assessments, 
while very few control offspring completed up to three 
repeated assessments. Main reasons for attrition were 
non-compliance: offspring found the protocol demand-
ing and many did not continue for this reason. Further, 
several offspring moved away as many were at the age of 
starting university, and therefore the protocol could not 
be continued. Sensitivity analyses were conducted: the 
offspring dropping out at the year-two assessment were 
not significantly different from offspring completing all 
yearly assessments in age or lifetime mood diagnosis (all 
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p > 0.05). In high-risk and control offspring, there were 
more males in the dropout group compared to the sam-
ple of offspring who completed all assessments (41 vs. 
26 % and 29 vs. 47 %, respectively). Owing to the small 
numbers of yearly repeat assessments in the controls, pri-
mary analyses with the control group are limited to base-
line cortisol measures.
Potential confounders were explored, including age, 
sex, BMI, SES, mean sleep quality of the night preced-
ing the sampling day, number of undesirable life events 
in the preceding year and awakening time when baseline 
cortisol sample was taken. There was no significant asso-
ciation between any of the potential confounding factors 
and cortisol measured by CAR, logAUC, and log evening 
cortisol (all p > 0.05).
Among the 53 high-risk offspring, 14 (26 %) developed 
a DSM-IV new onset mood episode (n = 9) or recurrence 
(n = 5) over study follow-up. In total, 26 (49 %) high-risk 
offspring were diagnosed with a DSM-IV lifetime mood 
disorder (major depression (MD), BD I, II, not other-
wise specified (NOS), dysthymia, depression NOS) but 
17 (32 %) of these cases developed prior to baseline. Five 
high-risk offspring had lifetime psychotic features and 
seven had a lifetime SUD. No control offspring developed 
diagnosable psychopathology over follow-up or had psy-
chopathology prior to baseline.
Between subjects differences (high risk vs. control)
Cortisol levels at baseline were highly variable in high-
risk and control offspring (Table 2). Mean baseline sali-
vary cortisol concentrations at all time points during the 
day did not differ between high-risk and control offspring 
(Fig.  1). Moreover, using adjusted mixed models, base-
line CAR, logT3, and logAUC were not significantly dif-
ferent between high-risk and control offspring (p = 0.38, 
p  =  0.30 and p  =  0.84), respectively (Additional file  1: 
Table S2).
Stability of cortisol concentrations over time
Unadjusted cortisol levels across repeated sampling years 
in high-risk and control offspring can be found in Fig. 2. 
Using adjusted mixed models, in high-risk offspring, 
there was no significant difference in cortisol levels 
across repeated sampling years (CAR: p = 0.45, logAUC: 
p  =  0.40, logT3: p  =  0.66). In controls, logT3 cortisol 
significantly increased over repeated sampling years 
(p  =  0.0077), while all other measurements of cortisol 
were stable over time (CAR: p = 0.25, logAUC: p = 0.86).
Within subject differences (high risk only)
Mean baseline cortisol levels within high-risk offspring 
can be found in Table 2. Mean baseline evening cortisol 
was higher among high-risk offspring with a new onset 
mood episode or recurrence (2.1  nmol/L, SD  =  1.7) 
compared to unaffected high-risk offspring (1.8 nmol/L, 
SD  =  1.8) (Table  2), although this was not statistically 
significant (p > 0.05).
To determine if cortisol levels predicted a new onset 
mood episode or recurrence among high-risk offspring 
(n =  14/53) over time, a longitudinal mixed model was 
computed accounting for annual repeated cortisol meas-
urements. Before adjustment for multiple compari-
sons, the pattern of logAUC and logT3 over repeated 
assessment times significantly increased the adjusted 
hazard of a new onset mood episode or recurrence 
by 2.7 times (p =  0.01, 95  % CI 1.2, 5.8), and 3.5 times 
(p = 0.01, 95 % CI 1.3, 9.4), respectively. However, after 
correction for multiple adjustments, these associations 
were no longer statistically significant (Šidák correction 
cutoff p  =  0.0043). The pattern of CAR over repeated 
Table 1 Baseline characteristics of  high-risk and  control 
offspring
SD standard deviation, SES socio-economic status, MFQ mood and feelings 
questionnaire
a Fisher’s exact test or Chi square
b T tests
c Poisson regression
d Hollingshead SES scale
e Peterson pubertal scale
f Pittsburgh sleep index







 Male 17 (32.08 %) 10 (45.45 %) 0.2718a
 Female 36 (67.92 %) 12 (54.55 %)
SESd n (%)
 1 (low) 0 0 0.3404a
 2 1 (1.89 %) 1 (4.55 %)
 3 1 (1.89 %) 2 (9.09 %)
 4 24 (45.28 %) 8 (36.36 %)
 5 (high) 27 (50.94 %) 11 (50.00 %)
Pubertal statuse n (%)
 1 (pre) 1 (2.08 %) 0 0.2045a
 2 2 (4.17 %) 0
 3 5 (10.42 %) 0
 4 11 (22.92 %) 1 (6.25 %)
 5 (post) 29 (60.42 %) 15 (93.75 %)
Body mass index mean (SD) 22.43 (4.50) 25.57 (3.60) 0.0122b
Age at baseline sample collection, 
mean (SD)
20.00 (7.23) 20.76 (2.76) 0.9632b
Mean MFQ score (SD) 10.60 (8.50) 6.20 (9.00) 0.0631b
Mean sleep qualityf (SD) 75.18 (13.75) 76.00 (12.87) 0.8210b
# of undesirable life events in  
previous yearg n (%)
1.09 (1.20) 0.83 (0.99) 0.3626c
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assessment times was not associated with the hazard of 
a new onset mood episode or recurrence over follow-up 
(HR 0.9, p = 0.19, 95 % CI 0.7, 1.1).
The influence of clinical characteristics
Using adjusted mixed models, in high-risk offspring with 
a lifetime mood disorder (n = 26/53), clinical character-
istics including lifetime psychotic symptoms, comorbid 
SUD, or parent lithium response did not significantly 
predict baseline CAR, logAUC, or logT3 cortisol (all 
p > 0.05) (Additional file 1: Table S3). There was no sig-
nificant interaction or main effect of offspring sex with 
psychotic symptoms, comorbid SUD and parent lithium 
response predicting all three baseline cortisol measure-
ments (all p > 0.05).
Using adjusted mixed models and accounting for mul-
tiple comparisons, in high-risk offspring with a lifetime 
mood disorder, there was no significant evidence that 
SUD or lifetime psychotic symptoms influenced the sta-
bility of CAR or logT3 over multiple years as evidenced 
Table 2 Mean baseline cortisol values (nmol/L) in high-risk and control offspring
Values are untransformed and unadjusted
SD standard deviation, CAR cortisol awakening response, AUC area under the curve (ground)




High‑risk High‑risk new mood episode/
recurrence
High‑risk unaffected Control
Mean SD n Mean SD n Mean SD n Mean SD n
CAR 1.5821 2.6985 53 1.1117 2.3158 14 1.4511 2.7074 27 1.1883 4.0286 22
Time 3a 1.7211 2.2336 53 2.1078 1.7483 14 1.7710 2.8267 27 1.9424 1.5352 21
AUCb 212,337.09 88,505.58 47 216,718.2277 92,904.24 14 206,593.52 99,296.26 23 265,085.77 185,938.31 19
Fig. 1 3‑day mean baseline saliva cortisol levels (nmol/L) at awakening (Time 0), 30 min later (Time 1), 60 min later (Time 2) and at 8:00 p.m. (Time 
3) in high‑risk and control offspring. Sample size in high‑risk group at Time 0: 53; Time 1: 53; Time 2: 12; Time 3: 53 and sample size in control group 
at Time 0: 22; Time 1: 22; Time 2: 3; Time 3: 21
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by non-significant interaction terms (p > 0.05) (Table 3). 
Before adjustment for multiple comparisons, lifetime 
psychotic symptoms significantly interacted with corti-
sol sampling year to predict logAUC (p  <  0.0001). Spe-
cifically, logAUC decreased over each sampling year from 
baseline among high-risk offspring with lifetime psy-
chotic symptoms, but remained stable over time among 
those without lifetime psychotic symptoms. Before 
adjustment for multiple comparisons, there was also a 
significant interaction between SUD and cortisol sam-
pling year predicting logAUC (p = 0.03) (Table 3). After 
applying a multiple comparisons correction, the only 
interaction that remained significant was between life-
time psychotic symptoms and logAUC (p = 0.0001).
There was a significant main effect of lifetime psy-
chotic symptoms predicting logT3 cortisol (p  =  0.04), 
where high-risk offspring with a mood disorder and psy-
chotic symptoms had 0.64  nmol/L units higher logT3 
cortisol compared to high-risk offspring with a mood 
disorder without psychotic symptoms after accounting 
for sampling year, age at baseline and sex. However, this 
effect was no longer significant when applying a multiple 
comparison correction (Table 3).
Discussion
This study examined the longitudinal association 
between salivary cortisol as measured by CAR, AUC and 
mean evening cortisol and mood episodes in offspring at 
high familial risk. Major findings included that salivary 
cortisol levels were more variable in controls compared 
to high-risk offspring, but did not differentiate high-risk 
from control offspring (Figs.  1, 2). Increasing AUC and 
mean evening cortisol significantly increased the hazard 
of a new onset or recurrence of a mood episode in high-
risk offspring by 2.7 and 3.5 times, respectively; however, 
after correction for multiple comparisons these fell short 
of statistical significance.
Salivary cortisol was quite stable over the repeated 
sampling years in high-risk and control offspring with 
the exception of evening 8:00 p.m. cortisol increasing in 
control offspring over time. The number of controls that 
completed the yearly cortisol assessment post-baseline 
was small; therefore, the latter finding should be inter-
preted with caution and may reflect random error. Life-
time psychotic symptoms in high-risk offspring with 
a remitted mood disorder significantly influenced the 
stability of cortisol daily secretion over repeated sam-
pling years as measured by AUC. In particular, a lifetime 
Fig. 2 a 3‑day mean saliva cortisol levels at awakening (T0), 30 min 
later (T1), 60 min later (T2) and at 8:00 p.m. (T3) across repeated sam‑
pling years in high‑risk offspring. b 3‑day mean saliva cortisol levels 
at awakening (T0), 30 min later (T1), 60 min later (T2) and at 8:00 p.m. 
(T3) across repeated sampling years in control offspring
Table 3 The influence of  DSM-IV substance use disorders 
and  lifetime psychotic symptoms on  the stability of  cor-
tisol (nmol/L) in  high-risk offspring over  repeated annual 
sampling assessments
Italic denotes significance after correction for multiple comparisons
SUD substance use disorders, CAR cortisol awakening response, AUC area under 
the curve (ground), Psychotic lifetime psychotic symptoms in or outside mood 
episodes
a p value not significant after Šidák correction for multiple comparisons (p value 
cutoff of 0.0034)
b Interaction term was composed of sampling assessment year and presence of 
lifetime SUD or psychotic symptoms
c Mixed model accounting for sibling correlation adjusted for sex and age at 
baseline cortisol sample
d 8:00 p.m. cortisol
e Seconds*nmol/L











CAR SUD 0.1733 0.1148 101
Psychotic 0.1687 0.1198 101
logTime 3d SUD 0.1633 0.8117 102
Psychotic 0.2728 0.0191a 102
logAUCe SUD 0.0346a 0.1831 95
Psychotic <0.0001 0.4902 95
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history of psychotic symptoms in high-risk offspring with 
a remitted mood disorder decreased salivary cortisol lev-
els over time compared to no change among those with-
out lifetime psychotic symptoms. In high-risk offspring 
with a lifetime mood disorder, a comorbid lifetime his-
tory of a SUD also influenced stability of daily secretion 
(AUC), where cortisol levels decreased over time among 
those with a prior SUD and remained stable among those 
without a SUD; however, the interaction pertaining to 
SUD did not maintain significance after adjustment for 
multiple comparisons. These interactions were also based 
on small samples sizes and, therefore, should be inter-
preted with caution. There were five high-risk offspring 
with psychotic symptoms at baseline and only one of 
these offspring completed a second annual repeated cor-
tisol assessment. Seven high-risk offspring had comorbid 
SUD at baseline, and only two of these offspring com-
pleted three repeated annual cortisol assessments.
Our findings were not consistent with those from 
a similar study of offspring of parents with BD that 
reported differences in the CAR between high-risk 
and control offspring. This Montreal-based study used 
MEMS TrackCap technology to time stamp the collec-
tion of samples which may be more reliable than our self-
report method of verifying timing of collection: although 
our cohort was well instructed and reported the actual 
sampling times. We had difficulty in compliance with our 
third morning sample (60  min post-awakening), which 
resulted in low sample sizes for this sampling time point. 
Several of our participants indicated that it was too dif-
ficult to complete this sample before eating breakfast and 
going to school or work.
The following limitations should be noted. Models per-
taining to new onset mood episode and recurrences were 
based on small numbers making more intricate within 
subject analyses challenging. Future research should 
examine the longitudinal association between salivary 
cortisol indices, and the subsequent onset of mood disor-
der and recurrences separately. The omission of the time 
2 sample (owing to low numbers) in the calculation of the 
AUC may possibly explain the non-significant findings 
as this may not have been able to effectively capture the 
complete rise in cortisol upon awakening. However, there 
is evidence of similar cortisol concentrations at 30 and 
60 min post-awakening in patients with major depression 
(McAllister-Williams et  al. 2015). The levels of cortisol 
in our sample were also highly variable in both high-risk 
and control offspring, potentially reflecting the high vari-
ability of basal salivary cortisol (Levine et al. 2007) and/or 
measurement error as well as the wide age range of our 
sample. To reduce the chance of Type II error, we had to 
limit the number of covariates (potential confounders) 
in our models. However, we explored several potential 
confounders and found that they were not associated 
with any of the cortisol measurements in high-risk and 
control offspring, including BMI. Moreover, models were 
adjusted for age and sex.
Salivary cortisol is a measure of acute change in free 
(unbound) cortisol and is highly sensitive to stress, daily 
activities, and consumption of numerous agents mak-
ing compliance essential to its accurate measurement. 
Although the measurement of cortisol through saliva has 
advantages such as non-invasiveness compared to other 
methods (Aardal and Holm 1995), the high variability, 
need for a demanding collection protocol, and difficulty 
with reproducibility of findings appears to limit its utility 
in clinical practice and research. Based on this compre-
hensive study in well-characterized youth, we conclude 
that a standardized test such as the dexamethasone sup-
pression test (DST) would be preferable to basal cortisol 
methods. The DST may require more invasive proce-
dures, but it is a well-validated prognostic measure in 
patients with a primary recurrent mood disorder. Pro-
spective study of the DST serially in remitted patients 
with lithium-responsive BD has proven clinical utility 
in identifying periods of heightened risk of recurrence 
by acting as a reliable barometer of underlying illness 
activity (Grof et  al. 1983). This has been important, for 
example, in informing safe periods for planned discon-
tinuation and for clinical monitoring to prevent relapse. 
Furthermore, in an unpublished clinical case series of 
symptomatic high-risk offspring who had not yet devel-
oped a diagnosable mood disorder (i.e., anxiety and panic 
disorder, circadian disturbances), the DST was uniformly 
positive during the acute episodes (Grof unpublished).
Conclusions
Basal salivary cortisol is stable over time in early adult-
hood among high-risk offspring. Further research with 
larger sample sizes and more refined longitudinal meth-
ods of cortisol measurement are needed to confirm the 
potential role of cortisol in the development of mood 
disorders among individuals at genetic risk for BD. Using 
the DST as a measure of illness propensity and develop-
ment in prospectively studied high-risk and control off-
spring is a promising avenue for future research given the 
high variability of findings pertaining to salivary cortisol 
across studies.
Additional file
Additional file 1: Table S1. Mean baseline sampling times in high‑risk 
and control offspring. Table S2. Baseline salivary cortisol (nmol/L) in 53 
high‑risk compared to 22 control offspring. Table S3. Clinical variables 
predicting baseline cortisol (nmol/L) in high‑risk offspring with a DSM‑IV 
mood disorder.
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